Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China

PHASE4CompletedINTERVENTIONAL
Enrollment

841

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Tiotropium

18 mcg tiotropium capsule, once daily, inhaled by HandiHaler, for 24 months

DRUG

placebo

placebo, once daily, inhaled by HandiHaler

Trial Locations (25)

100016

Beijing Chao-Yang Hospital, Beijing

200031

Shanghai Xuhui District Central Hospital, Shanghai

Zhongshan Hospital Fudan University, Shanghai

410005

The Second People's Hospital of Hunan Province, Changsha

423000

Chenzhou No.1 people's Hopital, Chenzhou

430030

Tongji Hospital,Tongji Medical College of HUST, Wuhan

450003

Henan Provincial People's Hospital, Zhengzhou

510080

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

510120

The First Affiliated Hospital of Guangzhou Medical College, Guangzhou

510150

Liwan Hospital,Guangzhou Medical College, Guangzhou

The Third Affiliated Hospital of Guangzhou Medical College, Guangzhou

510317

Guangdong No.2 Provincial People's Hospital, Guangzhou

510630

The First Affiliated Hospital of Jinan University, Guangzhou

511400

Guangzhou Panyu Center Hospital, Guangzhou

512000

The First People's Hospital of Shaoguan, Shaoguan

512032

Shaoguan Iron and Steel Group Company limited Hospital, Shaoguan

516001

Huizhou First Hospital, Huizhou

518052

Shenzhen Sixth People's Hospital, Shenzhen

524000

The second people's Hospital,Zhanjiang, Zhanjiang

524001

Affiliated Hospital of Guangdong Medical College, Zhanjiang

528000

The First People's Hospital of Foshan, Foshan

550000

The Affiliated Hospital of Guiyang Medical College, Guiyang

550002

Guizhou People's Hospital, Guiyang

630037

Xinqiao Hospital, Chongqing

2875303

Wengyuan County People's Hospital, Shaoguan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Rundo International Pharmaceutical Research & Development Co.,Ltd.

INDUSTRY

lead

The First Affiliated Hospital of Guangzhou Medical University

OTHER